Health
3 Reasons to Buy Moderna Now – Motley Fool
The shares have surged in the triple digits since the start of the year. And additional gains may be on the horizon.
Moderna(NASDAQ:MRNA) has taken center stage in the race to develop a coronavirus vaccine. In March, the clinical-stage biotech company became the first to bring a vaccine into human trials. Since then, management has reported encouraging trial data that allowed it to move on to phase 3 studies — a final and crucial step before regulatory approval. Since the start of the year, the shares have surged by 297%.
Some investors may wonder if, considering the share gains, there is any steam left. Of …
-
General12 hours agoChina and Philippines trade blame over latest South China Sea clash
-
Noosa News24 hours agoCat-Sitting Leads to Chaos for Austin Butler in the Trailer for Darren Aronofsky’s New Crime-Thriller ‘Caught Stealing’
-
Noosa News22 hours agoIs Auckland New Zealand’s New Cultural Capital?
-
General22 hours agoThree maps that show the scale of the NSW flood disaster